Markets:

Overview

News

Currencies

International

Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

4.150 +0.070 (+1.72%)

Streaming Delayed Price Updated: 12:43 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

Maravai Offloads Vector Labs To Private Equity ↗

September 07, 2021

Thompson Street Capital Partners, a private equity firm, has acquired Vector Laboratories, the Protein Detection business unit of Maravai Lifesciences Holdings Inc...

Via Benzinga

I-Mab Stock Flashes Vital Signs With 89 RS Rating ↗

September 01, 2021

I-Mab stock had its Relative Strength Rating upgraded from 70 to 89 on Wednesday. Is this biopharma stock on your radar?

Via Investor's Business Daily

Maravai LifeSciences - Pick Of The Day ↗

August 21, 2021

Healthcare company Maravai's stock hit 18 new highs and is up 51.06% in the last month.

Via Talk Markets

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

Genmab Stock Flashes Healthy RS Rating ↗

August 18, 2021

Genmab stock just cleared an important benchmark with an RS Rating upgrade from 79 to 82. Is Genmab on your watchlist?

Via Investor's Business Daily

Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Virpax Pharmaceuticals Shares Spike Higher ↗

August 17, 2021

Toward the end of trading Tuesday, the Dow traded down 1.18% to 35,204.03 while the NASDAQ fell 1.24% to 14,610.77. The S&P also fell, dropping 1.06% to 4,432.01. The U.S. has...

Via Benzinga

Topics Stocks

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

August 23, 2021

Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG...

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Stock Market Near Highs, Treasury Yields Rally; Disney, Several IPOs Jump On Earnings ↗

August 13, 2021

Stocks traded at highs this week despite some growth wobbles. Treasury yields rebounded. Disney and some IPOs jumped on earnings.

Via Investor's Business Daily

Topics Stocks

Arcturus Stock, A Covid Play, Flashes Vital Signs ↗

August 11, 2021

A Relative Strength Rating upgrade for Alcobra shows improving technical performance.

Via Investor's Business Daily

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

MRVI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Biotech Maravai LifeSciences Sees RS Rating Rise To 89 ↗

August 04, 2021

Maravai Lifesciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 89.

Via Investor's Business Daily

Topics Initial Public Offering

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Maravai Lifesciences Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

July 23, 2021

Maravai Lifesciences sees its Relative Strength Rating enter the 80-plus level.

Via Investor's Business Daily

Editas Medicine Stock Shows Improved Relative Strength Rating ↗

July 22, 2021

A Relative Strength Rating upgrade for Editas Medicine shows improving technical performance. Will it continue?

Via Investor's Business Daily

Codex DNA Shares Move Higher On Licensing, Supply Deal With TriLink For mRNA Capping Tech ↗

July 21, 2021

Codex DNA Inc (NASDAQ: DNAY) has announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences Holdings Inc...

Via Benzinga

BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold ↗

July 01, 2021

In a welcome move, biotech BridgeBio Pharma stock saw its Relative Strength Rating rise from 70 to 73 on Thursday.

Via Investor's Business Daily

Translate Bio Stock Sees Relative Strength Rating Jump To 88 ↗

June 30, 2021

A Relative Strength Rating upgrade for Translate Bio shows improving technical performance.

Via Investor's Business Daily

Translate Bio Stock Flashes Improved Technical Strength Rating; Triple-Digit Sales Growth ↗

June 28, 2021

Translate Bio shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Crispr Therapeutics Stock Sees Improved Relative Strength Rating ↗

June 25, 2021

Crispr Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 68 to 74.

Via Investor's Business Daily

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

Starting at $3.75/week.

Subscribe Today